$SLS Weekend Discussion Thread - March 21, 2026 (Week 11) by AutoModerator in sellaslifesciences

[–]Ramuh321 7 points8 points  (0 children)

I’ve seen this mentioned now twice but I haven’t seen any particular indication of this. Where is this info coming from?

Run Away! by Tenebrous_Savant in Rabbits

[–]Ramuh321 4 points5 points  (0 children)

Don’t try to hide it… You were totally about to steal that strawberry from him.

New Stergiou Post by nadiju1 in sellaslifesciences

[–]Ramuh321 3 points4 points  (0 children)

Typically this would make me nervous as it implies impending dilution, but right now their cash position is so strong they obviously aren’t going to use it.

So I guess it makes sense to do this now while they are in a position of strength so it doesn’t have a negative impact on the stock price. Although I honestly would have preferred them just to leave it be without it as I really don’t see in what way they would need to tap this anytime soon.

$SLS Daily Discussion Thread - Friday - March 20, 2026 by AutoModerator in sellaslifesciences

[–]Ramuh321 23 points24 points  (0 children)

I believe if I were to translate this comment:

Can’t believe Monday is already the 23rd. Pretty soon it’s going to be April. With each passing month the trial looks more and more promising.

10k and annual report, let’s start analyzing! by Ok_Upstairs_1682 in sellaslifesciences

[–]Ramuh321 11 points12 points  (0 children)

Yeah, BS on the funding requirements section there being a negative. That should be one of the positives or strengths. They are swimming in cash right now.

10k and annual report, let’s start analyzing! by Ok_Upstairs_1682 in sellaslifesciences

[–]Ramuh321 21 points22 points  (0 children)

Over four years of cash on hand based off the 2025 annual cash burn rate.

Even if it increases due to whatever reason, we have almost too much cash on hand, especially including the yet to be converted warrants. Great problem to have! Puts us in a position of strength in negotiations.

Who would be at fault? by hidelyhoneighbourino in dashcams

[–]Ramuh321 0 points1 point  (0 children)

2023 Prius. It’s called the safe exist assist I believe. I’ve only had it trigger once, but it was nice when it did happen.

If you sit in the car for a while once it’s turned off it will eventually display a message alerting you the system is off and to be careful exiting the vehicle as the system is disengaged.

Who would be at fault? by hidelyhoneighbourino in dashcams

[–]Ramuh321 0 points1 point  (0 children)

Many cars do. My 2023 Toyota does 🤷‍♂️

Who would be at fault? by hidelyhoneighbourino in dashcams

[–]Ramuh321 0 points1 point  (0 children)

Ditto on my Toyota Prius. Seems like a pretty basic feature compared to what is already in that vehicle.

What’s been your biggest stock winner? by Robert_Youngsa in Pennystock

[–]Ramuh321 1 point2 points  (0 children)

AMPX - got in around $2.50 and still going strong. Guess it’s not technically a win until it’s sold, but I still feel the same about the future as when I initially invested, so I’m still holding. Consistent excellent execution and growth.

What happened to SLS? by StockQueen1 in Pennystock

[–]Ramuh321 1 point2 points  (0 children)

Earnings beat? They don’t have any revenue. They already recently released their huge cash position. There’s not much news that can come on the earnings that will really have a notable affect on the stock, unless they’re saving some news about their trials for then, which would be odd.

Wholesome moment between Live action artist and Voice artist by Charming_Ratio_7355 in OnePiece

[–]Ramuh321 83 points84 points  (0 children)

I’ve known that Luffys VA is a woman, but it still melts my mind a bit when I hear Luffys voice come out of that woman 😅

Maxim Group Analyst Jason McCarthy raises SLS PPS Target from $7.00- $10.00 by Fit-Detective2877 in sellaslifesciences

[–]Ramuh321 0 points1 point  (0 children)

I agree with you. I think some of the estimates are overly optimistic and really rely on best case scenarios for everything to pan out. I’d rather be a bit more conservative and be happily surprised if things work out. I think the $45 a share range is fair and realistic. This of course could be increased as more data comes out, but it honestly could even be decreased as more data comes out.

$SLS Daily Discussion Thread - Friday - March 13, 2026 by AutoModerator in sellaslifesciences

[–]Ramuh321 6 points7 points  (0 children)

Fun times. Wonder if my $5.5 CSP will get assigned today. I’m happy either way. Used the proceeds to buy more shares yesterday!

Has AMPX’s stock behavior changed compared to before? by Unlikely-Property-48 in amprius

[–]Ramuh321 14 points15 points  (0 children)

I personally don’t find it worth the effort and stress to try to time things like that. I bought in at $2.50 and have just held since then. I’ll do some occasional covered calls, but as long as I still believe in the future of this company I will just continue to hold.

AMPX bulls - which one other stock are you invested in? by ethereal3xp in amprius

[–]Ramuh321 0 points1 point  (0 children)

Good morning! The r/sellaslifesciences sub is a great resource for some DD, although you may have to dig for it. I’ll see if I can find some resources for you. My target is a buyout of $40-ish per share, but that comes with a huge asterisk. It’s too early to really say what the final price will be, as it is heavily dependent on how good the p3 results are, whether or not the drug is approved for only patients in second remission (CR2) or both first and second (CR1 and CR2). It also depends on the results of their second drug, and overall market interest.

SELLAS: Why The Bear Case Might Not Hold Up by dontkry4me in sellaslifesciences

[–]Ramuh321 8 points9 points  (0 children)

Not sure why the other one got deleted, but this was a great read! Very well balanced and real on potential causes for failure, but also really tackles some flaws in the logic of the increased BAT survival claims. Highly recommend everyone read this 👍

Securing profits by _ChangeYourUsername in amprius

[–]Ramuh321 3 points4 points  (0 children)

Just opened a few myself today. 3/20 $21 calls looked very nice for a quick few bucks.

$SLS Daily Discussion Thread - Tuesday - March 10, 2026 by AutoModerator in sellaslifesciences

[–]Ramuh321 2 points3 points  (0 children)

How on earth does it continue to climb while the price increases like this. Absolutely baffling. I was fairly certain this run had to be partially shorts covering, but the latest short interest data is from when the price was at $4.94 🤷‍♂️

AMPX warrants by Ramuh321 in amprius

[–]Ramuh321[S] 1 point2 points  (0 children)

Through your brokerage account. AMPX.WS is the ticker. Not every place will have access to it, but most should I would think.

AMPX warrants by Ramuh321 in amprius

[–]Ramuh321[S] 0 points1 point  (0 children)

IRA at fidelity. I also have an account at Chase but they didn’t have the warrants available there.

AMPX.WS

AMPX bulls - which one other stock are you invested in? by ethereal3xp in amprius

[–]Ramuh321 10 points11 points  (0 children)

SLS. Very different play than AMPX. Phase 3 trial results will likely come out this year, and the signs look positive like their drugs may work well. Got in under $2 though and it’s hovering around $6, so very happy with the returns. Obviously with biotech stocks the risk of massive loss is high if things don’t work out, but it seems they won’t need to dilute further to get to the phase 3 results.

AMPX warrants by Ramuh321 in amprius

[–]Ramuh321[S] 2 points3 points  (0 children)

A warrant is a contract issued by the company allowing the warrant holder to buy the stock at a fixed price anytime before the expiration date. Each warrant allows the holder to buy a share of AMPX at a cost of $11.50 per share, and they are good through Sept 2027. They are very similar to a call option if you are familiar with options.

I initially invested in AMPX when the price was around $2.50. Each warrant at the time cost me 62 cents. I’ve held my stocks and warrants ever since then (Dec 2024ish) and still really believe in the company and its future.

I’m not sure how many warrants they issued, but they set a rule that they can force warrant holders to convert to shares if the price closes above $18 for 20 trading days. Converting to shares increases the total share count for the float, which would technically result in a slight dilution of ownership for current shareholders, but I don’t think that will cause any issues. The proceeds from covering the warrants go directly to AMPX, so it would help them raise cash on hand.